Literature DB >> 19818872

Acyl-CoA synthesis, lipid metabolism and lipotoxicity.

Lei O Li1, Eric L Klett, Rosalind A Coleman.   

Abstract

Although the underlying causes of insulin resistance have not been completely delineated, in most analyses, a recurring theme is dysfunctional metabolism of fatty acids. Because the conversion of fatty acids to activated acyl-CoAs is the first and essential step in the metabolism of long-chain fatty acid metabolism, interest has grown in the synthesis of acyl-CoAs, their contribution to the formation of signaling molecules like ceramide and diacylglycerol, and their direct effects on cell function. In this review, we cover the evidence for the involvement of acyl-CoAs in what has been termed lipotoxicity, the regulation of the acyl-CoA synthetases, and the emerging functional roles of acyl-CoAs in the major tissues that contribute to insulin resistance and lipotoxicity, adipose, liver, heart and pancreas. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818872      PMCID: PMC2824076          DOI: 10.1016/j.bbalip.2009.09.024

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  98 in total

1.  Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane.

Authors:  C E Gargiulo; S M Stuhlsatz-Krouper; J E Schaffer
Journal:  J Lipid Res       Date:  1999-05       Impact factor: 5.922

Review 2.  Bacterial long chain fatty acid transport: gateway to a fatty acid-responsive signaling system.

Authors:  Concetta C Dirusso; Paul N Black
Journal:  J Biol Chem       Date:  2004-08-30       Impact factor: 5.157

3.  Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.

Authors:  Cynthia G Van Horn; Jorge M Caviglia; Lei O Li; Shuli Wang; Deborah A Granger; Rosalind A Coleman
Journal:  Biochemistry       Date:  2005-02-08       Impact factor: 3.162

4.  Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy.

Authors:  Hsiu-Chiang Chiu; Attila Kovacs; Robert M Blanton; Xianlin Han; Michael Courtois; Carla J Weinheimer; Kathryn A Yamada; Sylvain Brunet; Haodong Xu; Jeanne M Nerbonne; Michael J Welch; Nicole M Fettig; Terry L Sharp; Nandakumar Sambandam; Krista M Olson; Daniel S Ory; Jean E Schaffer
Journal:  Circ Res       Date:  2004-12-23       Impact factor: 17.367

5.  Association of acyl-CoA synthetase-1 with GLUT4-containing vesicles.

Authors:  M W Sleeman; N P Donegan; R Heller-Harrison; W S Lane; M P Czech
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

6.  In vivo activities of cytokine oncostatin M in the regulation of plasma lipid levels.

Authors:  Weijia Kong; Parveen Abidi; Fredric B Kraemer; Jian-Dong Jiang; Jingwen Liu
Journal:  J Lipid Res       Date:  2005-03-16       Impact factor: 5.922

7.  A novel acyl-CoA synthetase, ACS5, expressed in intestinal epithelial cells and proliferating preadipocytes.

Authors:  E Oikawa; H Iijima; T Suzuki; H Sasano; H Sato; A Kamataki; H Nagura; M J Kang; T Fujino; H Suzuki; T T Yamamoto
Journal:  J Biochem       Date:  1998-09       Impact factor: 3.387

8.  Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes.

Authors:  Dawn L Brasaemle; Georgia Dolios; Lawrence Shapiro; Rong Wang
Journal:  J Biol Chem       Date:  2004-08-27       Impact factor: 5.157

9.  In vivo regulation of acyl-CoA synthetase mRNA and activity by endotoxin and cytokines.

Authors:  R A Memon; J Fuller; A H Moser; P J Smith; K R Feingold; C Grunfeld
Journal:  Am J Physiol       Date:  1998-07

10.  FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation.

Authors:  M Piccini; F Vitelli; M Bruttini; B R Pober; J J Jonsson; M Villanova; M Zollo; G Borsani; A Ballabio; A Renieri
Journal:  Genomics       Date:  1998-02-01       Impact factor: 5.736

View more
  86 in total

1.  Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin).

Authors:  Shi Hao Tan; Guanghou Shui; Jing Zhou; Jasmine Jia'En Li; Boon-Huat Bay; Markus R Wenk; Han-Ming Shen
Journal:  J Biol Chem       Date:  2012-03-09       Impact factor: 5.157

2.  Single-cell analysis of insulin-regulated fatty acid uptake in adipocytes.

Authors:  Oleg Varlamov; Romel Somwar; Anda Cornea; Paul Kievit; Kevin L Grove; Charles T Roberts
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-06-22       Impact factor: 4.310

3.  Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling.

Authors:  Chongben Zhang; Angela A Wendel; Matthew R Keogh; Thurl E Harris; Jie Chen; Rosalind A Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

4.  Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.

Authors:  Jakob A Shimshoni; Mireille Basselin; Lei O Li; Rosalind A Coleman; Stanley I Rapoport; Hiren R Modi
Journal:  Biochim Biophys Acta       Date:  2010-12-22

5.  A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway.

Authors:  Lichen Bao; Jun Yin; Wen Gao; Qun Wang; Wenbing Yao; Xiangdong Gao
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

6.  Sequence analysis of bovine C/EBPδ gene and its adipogenic effects on fibroblasts.

Authors:  Hong Wang; Gong Cheng; Changzhen Fu; Hongbao Wang; Wucai Yang; Hongcheng Wang; Linsen Zan
Journal:  Mol Biol Rep       Date:  2013-11-09       Impact factor: 2.316

7.  Glycerol-3-phosphate acyltransferase-4-deficient mice are protected from diet-induced insulin resistance by the enhanced association of mTOR and rictor.

Authors:  Chongben Zhang; Daniel E Cooper; Trisha J Grevengoed; Lei O Li; Eric L Klett; James M Eaton; Thurl E Harris; Rosalind A Coleman
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-17       Impact factor: 4.310

8.  Endothelial acyl-CoA synthetase 1 is not required for inflammatory and apoptotic effects of a saturated fatty acid-rich environment.

Authors:  Xin Li; Oscar Gonzalez; Xia Shen; Shelley Barnhart; Farah Kramer; Jenny E Kanter; Anuradha Vivekanandan-Giri; Kyoichiro Tsuchiya; Priya Handa; Subramaniam Pennathur; Francis Kim; Rosalind A Coleman; Jean E Schaffer; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-12-13       Impact factor: 8.311

9.  PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid omega-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease.

Authors:  James P Hardwick; Douglas Osei-Hyiaman; Homer Wiland; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  PPAR Res       Date:  2010-03-16       Impact factor: 4.964

10.  Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells.

Authors:  Daniel Hess; Jeffrey W Chisholm; R Ariel Igal
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.